Original Article
Association of Coffee Drinking with Total and Cause-Specific Mortality
N Engl J Med 2012; 366:1891-1904May 17, 2012DOI: 10.1056/NEJMoa1112010
- Abstract
Background
Coffee is one of the most widely consumed beverages, but the association between coffee consumption and the risk of death remains unclear.
Methods
We examined the association of coffee drinking with subsequent total and cause-specific mortality among 229,119 men and 173,141 women in the National Institutes of Health–AARP Diet and Health Study who were 50 to 71 years of age at baseline. Participants with cancer, heart disease, and stroke were excluded. Coffee consumption was assessed once at baseline.
Results
During 5,148,760 person-years of follow-up between 1995 and 2008, a total of 33,731 men and 18,784 women died. In age-adjusted models, the risk of death was increased among coffee drinkers. However, coffee drinkers were also more likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders, there was a significant inverse association between coffee consumption and mortality. Adjusted hazard ratios for death among men who drank coffee as compared with those who did not were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for drinking less than 1 cup per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups of coffee per day (P<0.001 for trend); the respective hazard ratios among women were 1.01 (95% CI, 0.96 to 1.07), 0.95 (95% CI, 0.90 to 1.01), 0.87 (95% CI, 0.83 to 0.92), 0.84 (95% CI, 0.79 to 0.90), and 0.85 (95% CI, 0.78 to 0.93) (P<0.001 for trend). Inverse associations were observed for deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections, but not for deaths due to cancer. Results were similar in subgroups, including persons who had never smoked and persons who reported very good to excellent health at baseline.
Conclusions
In this large prospective study, coffee consumption was inversely associated with total and cause-specific mortality. Whether this was a causal or associational finding cannot be determined from our data. (Funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.)
Media in This Article
Figure 1
Subgroup Analysis of Associations between the Consumption of 4 or More Cups of Coffee per Day and Total and Cause-Specific Mortality.Figure 2
Subgroup Analysis of Associations between the Consumption of 4 or More Cups of Coffee per Day and Total Mortality.Article Activity
- Article
Coffee is one of the most widely consumed beverages, both in the United States and worldwide. Since coffee contains caffeine, a stimulant, coffee drinking is not generally considered to be part of a healthy lifestyle. However, coffee is a rich source of antioxidants1 and other bioactive compounds, and studies have shown inverse associations between coffee consumption and serum biomarkers of inflammation2 and insulin resistance.3,4
Considerable attention has been focused on the possibility that coffee may increase the risk of heart disease,5,6 particularly since drinking coffee has been associated with increased low-density lipoprotein cholesterol levels7 and short-term increases in blood pressure.8 Results from a number of studies have been inconsistent.9,10 The heterogeneous findings may be due to differences between case–control and prospective study designs and possibly also to inconsistent control for important confounders such as tobacco smoking. In addition, the numbers of deaths have been small in most studies. Cohort studies do not support a positive association between coffee drinking and mortality, however, and some even suggest a modest inverse association.11-15
Previous studies have also investigated the association between coffee consumption and other major causes of death, and they have shown inverse associations with diabetes,4 inflammatory diseases,11 stroke,16-18 and injuries and accidents,19,20 although associations with cancer have generally been null.15,20-22 The results of studies of coffee consumption and total mortality have been mixed,15,20-31 with associations that have been consistent with either the null hypothesis or a modest inverse effect. Data are lacking to clarify the association between coffee drinking and mortality, to determine whether there is a dose–response relationship, and to assess whether associations are consistent across various subgroups.
We used data from a very large study, the National Institutes of Health (NIH)–AARP Diet and Health Study (ClinicalTrials.gov number, NCT00340015), to determine whether coffee consumption is associated with total or cause-specific mortality.32 The current analysis, involving more than 400,000 participants and 52,000 deaths, had ample power to detect even modest associations and allowed for subgroup analyses according to important baseline factors, including the presence or absence of adiposity and diabetes, as well as cigarette-smoking status.
Methods
Study Population
The NIH–AARP Diet and Health Study has been described previously.32 Between 1995 and 1996, a total of 617,119 AARP members, 50 to 71 years of age, returned a comprehensive questionnaire assessing diet and lifestyle. Participants resided in six states (California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania) and two metropolitan areas (Atlanta and Detroit). Of the respondents, 566,401 completed the questionnaire satisfactorily. Completion of the self-administered questionnaire was considered to imply informed consent to participate in the study.
We excluded from these analyses 15,760 persons whose questionnaires were completed by a spouse or other surrogate correspondent, as well as 51,234 persons with cancer, 65,044 with heart disease, 10,459 who had had a previous stroke, 2082 who did not provide information on coffee use, 15,820 who did not provide information on cigarette smoking, 3731 with an extremely low or high caloric consumption (two times as high as the 75th percentile of caloric intake or two times as low as the 25th percentile of caloric intake), and 11 who died before their completed questionnaire was received. The resulting analytic cohort included 229,119 men and 173,141 women. The NIH–AARP Diet and Health Study was approved by the Special Studies Institutional Review Board of the National Cancer Institute.
Assessment of Exposure
Participants completed a baseline questionnaire that assessed demographic and lifestyle characteristics and 124 dietary items, as previously described.32 Consumption of fruits, vegetables, red meat, white meat, and saturated fat were adjusted for total energy intake with the use of the nutrient-density approach (i.e., measured per 1000 kcal per day for food groups and as a percentage of total energy for saturated fat).
Coffee consumption was assessed according to 10 frequency categories, ranging from 0 to 6 or more cups per day. In addition, 96.5% of coffee drinkers provided information on whether they drank caffeinated or decaffeinated coffee more than half the time, and we used this information to categorize coffee drinkers.
In a subgroup of 1953 study participants who also completed a 24-hour dietary-recall questionnaire on 2 nonconsecutive days,33 the Spearman coefficient for the correlation between coffee consumption as assessed with this questionnaire and coffee consumption as assessed with the baseline food-frequency questionnaire was 0.80. The respective Spearman correlation coefficients for caffeinated and decaffeinated coffee were 0.64 and 0.48, respectively. Among participants who completed the 24-hour dietary-recall questionnaire, 79% drank ground coffee, 19% drank instant coffee, 1% drank espresso coffee, and 1% did not specify the type of coffee they consumed.
Cohort Follow-up
Participants were followed from baseline (1995–1996) until the date of death or December 31, 2008, whichever came first, by means of linkage to the National Change of Address database maintained by the U.S. Postal Service, specific change-of-address requests from participants, and updated addresses returned during other mailings. Vital status was assessed by periodic linkage of the cohort to the Social Security Administration Death Master File, linkage with cancer registries, questionnaire responses, and responses to other mailings.
Causes of Death
Specific causes of death were obtained through follow-up linkage to the National Death Index Plus, maintained by the National Center for Health Statistics. We used the International Classification of Diseases, Ninth Revision (ICD-9), and International Classification of Diseases, 10th Revision (ICD-10) codes to classify the underlying cause of death (obtained from death certificates) as follows: cancer (ICD-9, 140–239; ICD-10, C00–C97 and D00–D48), heart disease (ICD-9, 390–398, 401–404, 410–429, and 440–448; ICD-10, I00–I13, I20–I51, and I70–I78), respiratory disease (e.g., pneumonia, influenza, chronic obstructive pulmonary disease, and associated conditions) (ICD-9, 480–487 and 490–496; ICD-10, J10–J18 and J40–J47), stroke (ICD-9, 430–438; ICD-10, I60–I69), injuries and accidents (e.g., accident, suicide, and homicide) (ICD-9, 800–978; ICD-10, V01–X59, Y85–Y86, U03, X60–X84, Y87.0, U01–U02, X85–Y09, Y35, Y87.1, and Y89.0), diabetes (ICD-9, 250; ICD-10, E10–E14), infections (e.g., tuberculosis, septicemia, and other infectious and parasitic diseases) (ICD-9, 001–139; ICD-10, A00–B99), and all other causes.
State data on the incidence of cancer were obtained from the Arizona Cancer Registry, the Georgia Center for Cancer Statistics, the California Cancer Registry, the Michigan Cancer Surveillance Program, the Florida Cancer Data System, the Louisiana Tumor Registry, the New Jersey State Cancer Registry, the North Carolina Central Cancer Registry, the Pennsylvania Cancer Registry, and the Texas Cancer Registry.
Statistical Analysis
Coffee consumption was tabulated according to a number of dietary and lifestyle factors. Hazard ratios and 95% confidence intervals for mortality associated with coffee consumption were estimated with the use of Cox proportional-hazards regression models, with person-years as the underlying time metric; results calculated with age as the underlying time metric were similar. We tested the proportional-hazards assumption by modeling the interaction of follow-up time with coffee consumption and observed no significant deviations. Analyses were conducted with the use of SAS software, version 9.1. Statistical tests were two-sided, and P values of less than 0.05 were considered to indicate statistical significance.
We present risk estimates separately for men and women. Multivariate models were adjusted for the following baseline factors: age; body-mass index (BMI); race or ethnic group; level of education; alcohol consumption; the number of cigarettes smoked per day, use or nonuse of pipes or cigars, and time of smoking cessation (<1 year, 1 to <5 years, 5 to <10 years, or ≥10 years before baseline); health status; presence or absence of diabetes; marital status; level of physical activity; total energy intake; consumption of fruits, vegetables, red meat, white meat, and saturated fat; and use of any vitamin supplement (yes vs. no). In addition, risk estimates for death from cancer were adjusted for history of cancer (other than nonmelanoma skin cancer) in a first-degree relative (yes vs. no). For women, status with respect to postmenopausal hormone therapy was also included in multivariate models. Less than 5% of the cohort lacked any single covariate; for each covariate, we included an indicator for missing data in the regression models, if necessary. In a sensitivity analysis, we adjusted for propensity scores34 that reflected associations of coffee consumption with the other variables in the multivariate-adjusted models. Results obtained with the use of propensity-score adjustment were very similar to those from multivariate-adjusted models (Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org).
Hazard ratios for death associated with categories of coffee consumption (<1, 1, 2 or 3, 4 or 5, and ≥6 cups per day), as compared with no coffee consumption, were estimated from a single model. Tests of linear trend across categories of coffee consumption were performed by assigning participants the midpoint of their coffee-consumption category and entering this new variable into a separate Cox proportional-hazards regression model.
In secondary analyses, we determined risk estimates for categories of consumption of caffeinated and decaffeinated coffee and examined associations among prespecified baseline subgroups based on the following: follow-up time; age; cigarette-smoking status; presence or absence of diabetes; BMI; alcohol consumption; self-reported health; high or low consumption of red meat, white meat, fruits, and vegetables; use or nonuse of any vitamin supplement; and, in women, use or nonuse of postmenopausal hormone therapy. For these analyses, we combined the categories of 4 or 5 cups of coffee per day and 6 or more cups per day to preserve numbers in the top category of consumption. P values for interactions were computed by means of likelihood-ratio tests comparing Cox proportional-hazards models with and those without cross-product terms for each level of the baseline stratifying variable, with coffee consumption as an ordinal variable. For total mortality, we performed 12 interaction tests for men and 13 interaction tests for women. We also performed interaction tests for smoking status with eight different outcomes for both men and women. Several differences (P<0.05) would be expected by chance alone.
Results
Association of Coffee Consumption with Dietary and Lifestyle Factors
Coffee consumption at baseline was associated with several other dietary and lifestyle factors (Table 1Table 1
Baseline Characteristics of the Study Participants, According to Daily Coffee Consumption.). As compared with persons who did not drink coffee, coffee drinkers were more likely to smoke cigarettes and consume more than three alcoholic drinks per day, and they consumed more red meat. Coffee drinkers also tended to have a lower level of education; were less likely to engage in vigorous physical activity; and reported lower levels of consumption of fruits, vegetables, and white meat. However, coffee drinkers, especially women who drank coffee, were less likely to report having diabetes. About two thirds of coffee drinkers reported drinking predominantly caffeinated coffee.Coffee Consumption and Total Mortality
During 14 years of follow-up (median, 13.6 years; total person-years, 5,148,760), 33,731 men and 18,784 women died. In age-adjusted analyses, coffee consumption was associated with increased mortality among both men (Table 2Table 2
Association of Daily Coffee Consumption with Total and Cause-Specific Mortality among 229,119 Men.) and women (Table 3Table 3
Association of Daily Coffee Consumption with Total and Cause-Specific Mortality among 173,141 Women.). However, after multivariate adjustment for potential confounders, particularly smoking (Table 1 in the Supplementary Appendix), a modest inverse association between coffee drinking and total mortality was observed for both sexes. Hazard ratios for death among men who drank coffee, as compared with men who did not drink coffee, were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for less than 1 cup of coffee per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups (P<0.001 for trend across categories) (Table 2). Hazard ratios among women who drank coffee, as compared with those who did not, were as follows: 1.01 (95% CI, 0.96 to 1.07) for less than 1 cup of coffee per day, 0.95 (95% CI, 0.90 to 1.01) for 1 cup, 0.87 (95% CI, 0.83 to 0.92) for 2 or 3 cups, 0.84 (95% CI, 0.79 to 0.90) for 4 or 5 cups, and 0.85 (95% CI, 0.78 to 0.93) for 6 or more cups (P<0.001 for trend across categories) (Table 3).Coffee Consumption and Cause-Specific Mortality
Specific causes of death were also examined. After multivariate adjustment, coffee appeared to be inversely associated with most major causes of death in both men and women, including heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections. In contrast, there was no significant association between coffee consumption and deaths from cancer in women. There was a borderline positive association in men: among 13,402 deaths from cancer, 880 deaths were reported among men who drank 6 or more cups of coffee per day (hazard ratio for the comparison with men who did not drink coffee, 1.08; 95% CI, 0.98 to 1.19; P=0.02 for trend).
Subgroup Analyses
In analyses stratified according to the predominant type of coffee consumed (caffeinated or decaffeinated), the association of coffee drinking with total mortality and individual causes of death appeared to be similar for the two types of coffee (Figure 1Figure 1
Subgroup Analysis of Associations between the Consumption of 4 or More Cups of Coffee per Day and Total and Cause-Specific Mortality., and Table 2 and Table 3 in the Supplementary Appendix).Coffee consumption was associated with a number of risk factors for death. Results of subgroup analyses are shown in Figure 2Figure 2
Subgroup Analysis of Associations between the Consumption of 4 or More Cups of Coffee per Day and Total Mortality., with more detailed results shown in Table 4 and Table 5 in the Supplementary Appendix. Associations between coffee consumption and mortality were generally similar across subgroups stratified according to duration of follow-up and the following baseline factors: age; diabetes (yes vs. no); BMI; alcohol consumption; high or low consumption of red meat, white meat, fruits, and vegetables; use or nonuse of any vitamin supplement; and, in women, use or nonuse of postmenopausal hormone therapy. The largest differences across strata were observed for cigarette-smoking status, with stronger inverse associations between coffee drinking and mortality among men and women who never smoked or were former smokers than among those who were current smokers (P<0.001 for interaction in men and P=0.002 for interaction in women), and for self-reported health at baseline, with stronger associations among participants reporting good or very good to excellent health than among those reporting poor to fair health (P<0.001 for interaction in both men and women).We further examined associations between coffee consumption and deaths from cancer and other causes according to smoking status (Tables 6 and 7 in the Supplementary Appendix). The results were similar for most outcomes across categories of smoking status, with the exception of death from heart disease, with associations that appeared to be null in current smokers (P=0.002 for interaction in men and P=0.05 for interaction in women). We also noted significant interactions between smoking and coffee consumption with respect to the overall risk of death from cancer; associations appeared to be modestly inverse for men and women who had never smoked, but not for those who were former or current smokers. However, associations between coffee consumption and death from cancer were not significant for any single category of coffee consumption.
Discussion
In this large, prospective U.S. cohort study, we observed a dose-dependent inverse association between coffee drinking and total mortality, after adjusting for potential confounders (smoking status in particular). As compared with men who did not drink coffee, men who drank 6 or more cups of coffee per day had a 10% lower risk of death, whereas women in this category of consumption had a 15% lower risk. Similar associations were observed whether participants drank predominantly caffeinated or decaffeinated coffee. Inverse associations persisted among many subgroups, including participants who had never smoked and those who were former smokers and participants with a normal BMI and those with a high BMI. Associations were also similar for deaths that occurred in the categories of follow-up time examined (0 to <4 years, 4 to <9 years, and 9 to 14 years).
Our study was larger than prior studies, and the number of deaths (>52,000) was more than twice that in the largest previous study.22 Whereas the results of previous small studies have been inconsistent, our results are similar to those of several larger, more recent studies, including the Health Professionals Follow-up Study and the Nurses' Health Study.21 In the Health Professionals Follow-up Study, the hazard ratio for death among men who drank 6 or more cups of coffee per day, as compared with men who drank less than 1 cup per month, was 0.80 (95% CI, 0.62 to 1.04). In the Nurses' Health Study, the corresponding hazard ratio for women was 0.83 (95% CI, 0.73 to 0.95). In the Japan Collaborative Cohort Study for Evaluation of Cancer Risk,22 the hazard ratio for death among men who drank 4 or more cups of coffee per day, as compared with men who drank less than 1 cup per day, was 0.80 (95% CI, 0.68 to 0.95); the corresponding hazard ratio for women was 0.89 (95% CI, 0.66 to 1.20). In the Miyagi Cohort Study,15 the hazard ratio for death among men who drank 3 or more cups of coffee per day, as compared with men who never drank coffee, was 0.89 (95% CI, 0.74 to 1.08); the corresponding hazard ratio for women was 0.75 (95% CI, 0.53 to 1.05).
We noted inverse associations between coffee drinking and most major causes of death, with the exception of cancer. Associations between coffee drinking and the risk of death from heart disease have been particularly controversial, and several studies have suggested an increased risk among coffee drinkers.9,10 Nevertheless, the inverse associations observed in our study are consistent with those in a recent meta-analysis of this association. In that analysis, the relative risk of death among men in the highest category of coffee consumption, as compared with men in the lowest category of coffee consumption, was 0.89 (95% CI, 0.78 to 1.03).10 Although some previous studies showed differences in risk according to the interval between baseline and the date of death,9 we observed similar associations for deaths occurring early or late in follow-up.
Our results are concordant with previous studies showing inverse associations between coffee consumption and diabetes,4 stroke,16-18 and death due to inflammatory diseases.11 In addition, we observed an inverse association of coffee consumption with deaths from injuries and accidents. The mechanism of this association is unclear and could reflect chance or residual confounding, although similar results were reported in the Nurses' Health Study and the Kaiser Permanente Multiphasic Health Checkup cohorts.19,20 In contrast to other outcomes, a modest borderline positive association was observed in men for coffee consumption and mortality from cancer, with a null association observed in women. Findings from previous studies were typically null.15,20-22
Several explanations for our findings are possible. As in all observational studies, associations could reflect confounding by unmeasured or poorly measured confounders. Although coffee consumption was inversely associated with diabetes, it was also positively associated with a number of behaviors that are considered unhealthy and are associated with an increased risk of death, such as tobacco smoking,35 consumption of red meat,36 and heavy alcohol use.37 Tobacco smoking was the strongest confounder in the multivariate analysis, and the inverse association between coffee consumption and mortality tended to be stronger among persons who had never smoked or were former smokers than among those who were current smokers, suggesting that residual confounding by smoking status, if present, attenuated the inverse associations between coffee drinking and mortality in our study.
Reverse causality is another possible explanation, since persons with chronic disease and poor health might abstain from coffee drinking. However, we excluded persons who had cancer or cardiovascular disease at baseline. Moreover, the results were similar when data from the first 4 or 9 years of follow-up were excluded, and associations were stronger among persons reporting good or very good to excellent health at baseline than among those reporting poor to fair health, arguing against this possibility.
Several limitations of our study should be noted. Coffee consumption was assessed by self-report at a single time point and may not reflect long-term patterns of consumption. The distinction between persons who drank caffeinated coffee and those who drank decaffeinated coffee was subject to misclassification, since these categories were defined on the basis of consumption of either beverage more than half the time. We lacked data on how coffee was prepared (espresso, boiled, or filtered), and the constituents of coffee may differ according to the method of preparation.
Given the observational nature of our study, it is not possible to conclude that the inverse relationship between coffee consumption and mortality reflects cause and effect. However, we can speculate about plausible mechanisms by which coffee consumption might have health benefits. Coffee contains more than 1000 compounds that might affect the risk of death. The most well-studied compound is caffeine, although similar associations for caffeinated and decaffeinated coffee in the current study and a previous study21 suggest that, if the relationship between coffee consumption and mortality were causal, other compounds in coffee (e.g., antioxidants, including polyphenols) might be important.1,38
In summary, this large prospective cohort study showed significant inverse associations of coffee consumption with deaths from all causes and specifically with deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections. Our results provide reassurance with respect to the concern that coffee drinking might adversely affect health.
Supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.
The views expressed in this article are those of the authors and do not necessarily reflect those of the cancer registries.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
We thank the participants in this study for their outstanding cooperation.
This article is dedicated to the memory of Arthur Schatzkin, the visionary investigator who founded the NIH–AARP Diet and Health Study.
Source Information
From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD (N.D.F., Y.P., C.C.A., R.S.); and AARP, Washington, DC (A.R.H.).
Address reprint requests to Dr. Freedman at the Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd., EPS/320, MSC 7232, Rockville, MD 20852, or at freedmanne@mail.nih.gov.
- References
References
1
Gomez-Ruiz JA Leake DS Ames JM
CrossRef | Web of Science | Medline2
Lopez-Garcia E van Dam RM Qi L Hu FB
Web of Science | Medline3
Arion WJ Canfield WK Ramos FC
CrossRef | Web of Science | Medline4
Huxley R Lee CM Barzi F
CrossRef | Web of Science | Medline5
Coffee drinking and acute myocardial infarction: report from the Boston Collaborative Drug Surveillance Program. Lancet 1972;2:1278-1281
Web of Science | Medline6
Jick H Miettinen OS Neff RK Shapiro S Heinonen OP Slone D
Full Text | Web of Science | Medline7
Jee SH He J Appel LJ
CrossRef | Web of Science | Medline8
Noordzij M Uiterwaal CS Arends LR Kok FJ Grobbee DE Geleijnse JM
CrossRef | Web of Science | Medline9
Greenland S
CrossRef | Web of Science | Medline10
Wu JN Ho SC Zhou C
CrossRef | Web of Science | Medline11
Andersen LF Jacobs DR Jr Carlsen MH Blomhoff R
Web of Science | Medline12
Greenberg JA Chow G Ziegelstein RC
CrossRef | Web of Science | Medline13
Lopez-Garcia E van Dam RM Willett WC
CrossRef | Web of Science | Medline14
Mineharu Y Koizumi A Wada Y
CrossRef | Web of Science | Medline15
Sugiyama K Kuriyama S Akhter M
CrossRef | Web of Science | Medline16
Larsson SC Mannisto S Virtanen MJ Kontto J Albanes D Virtamo J
CrossRef | Web of Science | Medline17
Larsson SC Virtamo J Wolk A
CrossRef | Web of Science | Medline18
Lopez-Garcia E Rodriguez-Artalejo F Rexrode KM Logroscino G Hu FB van Dam RM
CrossRef | Web of Science | Medline19
Kawachi I Willett WC Colditz GA Stampfer MJ Speizer FE
CrossRef | Web of Science | Medline20
Klatsky AL Armstrong MA Friedman GD
CrossRef | Medline21
Lopez-Garcia E van Dam RM Li TY Rodriguez-Artalejo F Hu FB
CrossRef | Web of Science | Medline22
Tamakoshi A Lin Y Kawado M Yagyu K Kikuchi S Iso H
CrossRef | Web of Science | Medline23
Happonen P Laara E Hiltunen L Luukinen H
CrossRef | Web of Science | Medline24
Heyden S Tyroler HA Heiss G Hames CG Bartel A
CrossRef | Web of Science | Medline25
Iwai N Ohshiro H Kurozawa Y
CrossRef | Medline26
Jacobsen BK Bjelke E Kvale G Heuch I
Web of Science | Medline27
Kleemola P Jousilahti P Pietinen P Vartiainen E Tuomilehto J
CrossRef | Web of Science | Medline28
LeGrady D Dyer AR Shekelle RB
Web of Science | Medline29
Lindsted KD Kuzma JW Anderson JL
CrossRef | Web of Science | Medline30
Paganini-Hill A Kawas CH Corrada MM
CrossRef | Web of Science | Medline31
Woodward M Tunstall-Pedoe H
CrossRef | Web of Science | Medline32
Schatzkin A Subar AF Thompson FE
CrossRef | Web of Science | Medline33
Thompson FE Kipnis V Midthune D
Web of Science | Medline34
D'Agostino RB Jr
CrossRef | Web of Science | Medline35
Oza S Thun MJ Henley SJ Lopez AD Ezzati M
CrossRef | Web of Science | Medline36
Sinha R Cross AJ Graubard BI Leitzmann MF Schatzkin A
CrossRef | Web of Science | Medline37
Zaridze D Brennan P Boreham J
CrossRef | Web of Science | Medline38
Yanagimoto K Lee KG Ochi H Shibamoto T
CrossRef | Web of Science | Medline
- Citing Articles (137)
Citing Articles
1
Filippo Giorgio Di Girolamo, Sara Mazzucco, Roberta Situlin, Nina Mohorko, Zala Jenko-Pražnikar, Ana Petelin, Marcello Tence, Rado Pišot, Luciano Navarini, Gianni Biolo. (2016) Roasting intensity of naturally low-caffeine Laurina coffee modulates glucose metabolism and redox balance in humans. Nutrition 32:9, 928-936
CrossRef2
Flavie Letois, Thibault Mura, Jacqueline Scali, Laure-Anne Gutierrez, Catherine Féart, Claudine Berr. (2016) Nutrition and mortality in the elderly over 10 years of follow-up: the Three-City study. British Journal of Nutrition 116:05, 882-889
CrossRef3
André Luiz Buzzo Mori, Daneysa Lahis Kalschne, Maria Amélia Gava Ferrão, Aymbiré Francisco Almeida da Fonseca, Romário Gava Ferrão, Marta de Toledo Benassi. (2016) Diterpenes in Coffea canephora. Journal of Food Composition and Analysis 52, 52-57
CrossRef4
Antihypertension Effects of Green Coffee Bean Extract and Chlorogenic Acids. 2016:, 133-143.
CrossRef5
Eric T. Trexler, Abbie E. Smith-Ryan, Erica J. Roelofs, Katie R. Hirsch, Meredith G. Mock. (2016) Effects of coffee and caffeine anhydrous on strength and sprint performance. European Journal of Sport Science 16:6, 702-710
CrossRef6
Larissa Fortunato Araújo, Saira Saeed Mirza, Daniel Bos, Wiro J. Niessen, Sandhi Maria Barreto, Aad van der Lugt, Meike W. Vernooij, Albert Hofman, Henning Tiemeier, M. Arfan Ikram, M. Cristina Polidori. (2016) Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study. Journal of Alzheimer's Disease 53:2, 451-461
CrossRef7
Saverio Caini, Sofia Cattaruzza, Benedetta Bendinelli, Giulio Tosti, Giovanna Masala, Patrizia Gnagnarella, Melania Assedi, Ignazio Stanganelli, Domenico Palli, Sara Gandini. (2016) Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. European Journal of Nutrition
CrossRef8
Jorien L. Treur, Amy E. Taylor, Jennifer J. Ware, George McMahon, Jouke-Jan Hottenga, Bart M. L. Baselmans, Gonneke Willemsen, Dorret I. Boomsma, Marcus R. Munafò, Jacqueline M. Vink. (2016) Associations between smoking and caffeine consumption in two European cohorts. Addiction 111:6, 1059-1068
CrossRef9
Veeravich Jaruvongvanich, Anawin Sanguankeo, Nattawat Klomjit, Sikarin Upala. (2016) Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology
CrossRef10
Tuan Pham, Travis B. Dick, Michael R. Charlton. (2016) Nonalcoholic Fatty Liver Disease and Liver Transplantation. Clinics in Liver Disease 20, 403-417
CrossRef11
Hiroyuki Sasaki, Ai Hirasawa, Takuro Washio, Shigehiko Ogoh. (2016) Acute effect of coffee drinking on dynamic cerebral autoregulation. European Journal of Applied Physiology 116, 879-884
CrossRef12
Viktor Oskarsson, Omid Sadr-Azodi, Nicola Orsini, Alicja Wolk. (2016) A prospective cohort study on the association between coffee drinking and risk of non-gallstone-related acute pancreatitis. British Journal of Nutrition 115, 1830-1834
CrossRef13
James G. Phillips, C. Erik Landhuis, Daniel Shepherd, Rowan P. Ogeil. (2016) Online Activity Levels Are Related to Caffeine Dependency. Cyberpsychology, Behavior, and Social Networking 19:5, 352-356
CrossRef14
O. J. Kennedy, P. Roderick, R. Buchanan, J. A. Fallowfield, P. C. Hayes, J. Parkes. (2016) Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Alimentary Pharmacology & Therapeutics 43:10.1111/apt.2016.43.issue-5, 562-574
CrossRef15
Manav Wadhawan, Anil C. Anand. (2016) Coffee and Liver Disease. Journal of Clinical and Experimental Hepatology 6:1, 40-46
CrossRef16
Mary E. Rinella, Arun J. Sanyal. (2016) Management of NAFLD: a stage-based approach. Nature Reviews Gastroenterology and Hepatology 13, 196-205
CrossRef17
Haripriya Maddur, Brent A. Neuschwander-Tetri. . Should physicians be prescribing or patients self-medicating with orlistat, vitamin E, vitamin D, insulin sensitizers, pentoxifylline, or coffee?. 2016:, 182-188.
CrossRef18
Nadia Bastide, Laureen Dartois, Valérie Dyevre, Laure Dossus, Guy Fagherazzi, Mauro Serafini, Marie-Christine Boutron-Ruault. (2016) Dietary antioxidant capacity and all-cause and cause-specific mortality in the E3N/EPIC cohort study. European Journal of Nutrition
CrossRef19
Onni Niemelä. (2016) Biomarker-Based Approaches for Assessing Alcohol Use Disorders. International Journal of Environmental Research and Public Health 13, 166
CrossRef20
Sebastian C. Holst, Amandine Valomon, Hans-Peter Landolt. (2016) Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy. Annual Review of Pharmacology and Toxicology 56:1, 577-603
CrossRef21
James G. Phillips, Jonathan Currie, Rowan P. Ogeil. (2016) Consumption and foraging behaviors for common stimulants (nicotine, caffeine). Journal of Addictive Diseases 35, 15-21
CrossRef22
Rohit S. Loomba, Saurabh Aggarwal, Rohit R. Arora. (2016) The Effect of Coffee and Quantity of Consumption on Specific Cardiovascular and All-Cause Mortality. American Journal of Therapeutics 23, e232-e237
CrossRef23
Ian Clark, Hans Peter Landolt. (2016) Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Medicine Reviews
CrossRef24
Jorien L. Treur, Amy E. Taylor, Jennifer J. Ware, Michel G. Nivard, Michael C. Neale, George McMahon, Jouke-Jan Hottenga, Bart M. L. Baselmans, Dorret I. Boomsma, Marcus R. Munafò, Jacqueline M. Vink. (2016) Smoking and caffeine consumption: a genetic analysis of their association. Addiction Biology
CrossRef25
Yenisetti SC, Muralidhara, . (2016) Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview. AIMS Public Health 3:2, 407-422
CrossRef26
Jessika Cristina Bridi, Alexandre Guimarães de Almeida Barros, Letícia Reis Sampaio, Júlia Castro Damásio Ferreira, Felix Alexandre Antunes Soares, Marco Aurélio Romano-Silva. (2015) Lifespan Extension Induced by Caffeine in Caenorhabditis elegans is Partially Dependent on Adenosine Signaling. Frontiers in Aging Neuroscience 7
CrossRef27
Christiane Barthel, Sandra Wiegand, Sylvie Scharl, Michael Scharl, Pascal Frei, Stephan R. Vavricka, Michael Fried, Michael Christian Sulz, Nico Wiegand, Gerhard Rogler, Luc Biedermann. (2015) Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey. Nutrition Journal 14
CrossRef28
Stefan Enroth, Sofia Bosdotter Enroth, Åsa Johansson, Ulf Gyllensten. (2015) Protein profiling reveals consequences of lifestyle choices on predicted biological aging. Scientific Reports 5, 17282
CrossRef29
Thomas P. Thomopoulos, Evangelos Ntouvelis, Andreas-Antonios Diamantaras, Marianna Tzanoudaki, Margarita Baka, Emmanuel Hatzipantelis, Maria Kourti, Sophia Polychronopoulou, Vasiliki Sidi, Eftichia Stiakaki, Maria Moschovi, Maria Kantzanou, Eleni Th. Petridou. (2015) Maternal and childhood consumption of coffee, tea and cola beverages in association with childhood leukemia: a meta-analysis. Cancer Epidemiology 39, 1047-1059
CrossRef30
Erikka Loftfield, Neal D. Freedman, Barry I. Graubard, Kristin A. Guertin, Amanda Black, Wen-Yi Huang, Fatma M. Shebl, Susan T. Mayne, Rashmi Sinha. (2015) Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. American Journal of Epidemiology, kwv146
CrossRef31
James G. Phillips, Rowan P. Ogeil. (2015) Decision-making style, nicotine and caffeine use and dependence. Human Psychopharmacology: Clinical and Experimental 30:10.1002/hup.v30.6, 442-450
CrossRef32
Christopher D Hingston, Matt P Wise. (2015) Coffee brewing technique as a confounder in observational studies. Heart 101, 1686-1686
CrossRef33
Nathan Seppa. (2015) The Beneficial Bean: Coffee reveals itself as an unlikely health elixir. Science News 188:10.1002/scin.v188.7, 16-19
CrossRef34
Karen M. Eny, Trevor J. Orchard, Rachel Grace Miller, John Maynard, Denis M. Grant, Tina Costacou, Patricia A. Cleary, Barbara H. Braffett, , Andrew D. Paterson. (2015) Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. Diabetes Technology & Therapeutics 17, 726-734
CrossRef35
Stephan Martin. (2015) Nicht alles, was Spaß macht und gut schmeckt, ist verboten!. Info Diabetologie 9, 43-49
CrossRef36
Masaki Shinoda, Motoharu Fujii, Osamu Takahashi, Akiko Kawatsu, Akihiro Uemura, Yasunari Niimi. (2015) Inverse Relationship between Coffee Consumption and Cerebral Microbleeds in Men, but Not Women. Journal of Stroke and Cerebrovascular Diseases 24, 2196-2199
CrossRef37
Yoshinori Mikami, Toshiko Yamazawa. (2015) Chlorogenic acid, a polyphenol in coffee, protects neurons against glutamate neurotoxicity. Life Sciences 139, 69-74
CrossRef38
Maria Hernandez-Rodas, Rodrigo Valenzuela, Luis Videla. (2015) Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 16, 25168-25198
CrossRef39
T Imatoh, S Kamimura, M Miyazaki. (2015) Coffee but not green tea consumption is associated with prevalence and severity of hepatic steatosis: the impact on leptin level. European Journal of Clinical Nutrition 69, 1023-1027
CrossRef40
Marie Löf, Sven Sandin, Li Yin, Hans-Olov Adami, Elisabete Weiderpass. (2015) Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women. European Journal of Epidemiology 30, 1027-1034
CrossRef41
Steven G. Chrysant. (2015) Coffee Consumption and Cardiovascular Health. The American Journal of Cardiology 116:5, 818-821
CrossRef42
Daniel Lindholm, Robert F. Storey, Christina Christersson, Sigrun Halvorsen, Erik L. Grove, Oscar Ö. Braun, Christoph Varenhorst, Stefan K. James. (2015) Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr. American Heart Journal 170:3, 465-470
CrossRef43
J. Fromonot, P. Deharo, L. Bruzzese, T. Cuisset, J. Quilici, S. Bonatti, E. Fenouillet, G. Mottola, J. Ruf, R. Guieu. (2015) Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. Canadian Journal of Physiology and Pharmacology, 1-6
CrossRef44
Elinor Fondell, ÉIlis J. O’Reilly, Kathryn C. Fitzgerald, Guido J. Falcone, Laurence N. Kolonel, Yikyung Park, Susan M. Gapstur, Alberto Ascherio. (2015) Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16, 366-371
CrossRef45
Kerstin Kempf, Hubert Kolb, Babette Gärtner, Gerhard Bytof, Herbert Stiebitz, Ingo Lantz, Roman Lang, Thomas Hofmann, Stephan Martin. (2015) Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial. European Journal of Nutrition 54, 845-854
CrossRef46
Natalia Khalaf, Donna White, Fasiha Kanwal, David Ramsey, Sahil Mittal, Shahriar Tavakoli-Tabasi, Jill Kuzniarek, Hashem B. El-Serag. (2015) Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clinical Gastroenterology and Hepatology 13, 1521-1531.e3
CrossRef47
K. A. Guertin, N. D. Freedman, E. Loftfield, B. I. Graubard, N. E. Caporaso, R. Sinha. (2015) Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. International Journal of Epidemiology
CrossRef48
T. Walter, J. Grüttner, M. Borggrefe, S. Swoboda. (2015) Schokolade, Alkohol und Kaffee. Der Kardiologe 9, 253-264
CrossRef49
I. Raymond Thomason, Michael Charlton. (2015) An Update of Liver Transplantation for Nonalcoholic Steatohepatitis. Current Hepatology Reports 14, 99-108
CrossRef50
Yuni Choi, Yoosoo Chang, Seungho Ryu, Juhee Cho, Sanjay Rampal, Yiyi Zhang, Jiin Ahn, Joao A C Lima, Hocheol Shin, Eliseo Guallar. (2015) Coffee consumption and coronary artery calcium in young and middle-aged asymptomatic adults. Heart 101, 686-691
CrossRef51
K. Castetbon. (2015) Rôle du café dans la prévention primaire du diabète de type 2 : Arguments épidémiologiques récents. Médecine des Maladies Métaboliques 9, 292-298
CrossRef52
Yimin Zhao, Kejian Wu, Jusheng Zheng, Ruiting Zuo, Duo Li. (2015) Association of coffee drinking with all-cause mortality: a systematic review and meta-analysis. Public Health Nutrition 18, 1282-1291
CrossRef53
(2015) Scientific Opinion on the safety of caffeine. EFSA Journal 13:5, 4102
CrossRef54
Christian C. Abnet, Douglas A. Corley, Neal D. Freedman, Farin Kamangar. (2015) Diet and Upper Gastrointestinal Malignancies. Gastroenterology 148:6, 1234-1243.e4
CrossRef55
A. T. Nordestgaard, M. Thomsen, B. G. Nordestgaard. (2015) Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. International Journal of Epidemiology 44, 551-565
CrossRef56
Shira Zelber-Sagi, Federico Salomone, Muriel Webb, Roni Lotan, Hanny Yeshua, Zamir Halpern, Erwin Santo, Ran Oren, Oren Shibolet. (2015) Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Translational Research 165, 428-436
CrossRef57
S G Chrysant, G S Chrysant. (2015) Cardiovascular complications from consumption of high energy drinks: recent evidence. Journal of Human Hypertension 29, 71-76
CrossRef58
Katsuhiko Noguchi, Toshihiro Matsuzaki, Mayuko Sakanashi, Naobumi Hamadate, Taro Uchida, Mika Kina-Tanada, Haruaki Kubota, Junko Nakasone, Matao Sakanashi, Shinichiro Ueda, Hiroaki Masuzaki, Shogo Ishiuchi, Yusuke Ohya, Masato Tsutsui. (2015) Effect of caffeine contained in a cup of coffee on microvascular function in healthy subjects. Journal of Pharmacological Sciences 127, 217-222
CrossRef59
Beth Levine, Milton Packer, Patrice Codogno. (2015) Development of autophagy inducers in clinical medicine. Journal of Clinical Investigation 125, 14-24
CrossRef60
Sunghee Lee, Wookyoun Cho, Namhan Cho, Chol Shin. (2015) The association between Coffee Consumption and All-cause Mortality According to Sleep-related Disorders. Korean Journal of Community Nutrition 20, 301
CrossRef61
Jeanine M. Genkinger, Valerie Gebara. . Coffee Intake and Pancreatic Cancer Risk. 2015:, 367-374.
CrossRef62
Adriana Farah, Giselle Duarte. . Bioavailability and Metabolism of Chlorogenic Acids from Coffee. 2015:, 789-801.
CrossRef63
Takuya Imatoh. . Coffee Consumption and Adiponectin. 2015:, 507-515.
CrossRef64
Meir Djaldetti, Michael Bergman, Hertzel Salman, Hanna Bessler. . On the Linkage between Caffeine, Cytokine Secretion, and Cancer. 2015:, 645-653.
CrossRef65
Ilaria Zanotti, Margherita Dall'Asta, Pedro Mena, Laura Mele, Renato Bruni, Sumantra Ray, Daniele Del Rio. (2015) Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food Funct. 6, 13-31
CrossRef66
Churchill Lukwiya Onen. . Epidemiology of Cardiovascular Toxins. 2015:, 1-44.
CrossRef67
Qian Xiao, Rashmi Sinha, Barry I. Graubard, Neal D. Freedman. (2014) Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010. Hepatology 60:10.1002/hep.v60.6, 2091-2098
CrossRef68
Gina A. Montoya, Tamara Bakuradze, Marion Eirich, Thomas Erk, Matthias Baum, Michael Habermeyer, Gerhard Eisenbrand, Elke Richling. (2014) Modulation of 3′,5′-cyclic AMP homeostasis in human platelets by coffee and individual coffee constituents. British Journal of Nutrition 112, 1427-1437
CrossRef69
A. Crippa, A. Discacciati, S. C. Larsson, A. Wolk, N. Orsini. (2014) Coffee Consumption and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Dose-Response Meta-Analysis. American Journal of Epidemiology 180, 763-775
CrossRef70
Sean W.P. Koppe. (2014) Obesity and the liver: nonalcoholic fatty liver disease. Translational Research 164, 312-322
CrossRef71
Craig Lammert, Brian D. Juran, Erik Schlicht, Xiao Xie, Elizabeth J. Atkinson, Mariza de Andrade, Konstantinos N. Lazaridis. (2014) Reduced Coffee Consumption Among Individuals With Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis. Clinical Gastroenterology and Hepatology 12, 1562-1568
CrossRef72
Radhika Kumari, W. Ray Kim. (2014) Coffee: A Panacea or Snake Oil for the Liver?. Clinical Gastroenterology and Hepatology 12, 1569-1571
CrossRef73
Idris Guessous, Chin B. Eap, Murielle Bochud. (2014) Blood Pressure in Relation to Coffee and Caffeine Consumption. Current Hypertension Reports 16
CrossRef74
Kiran Bambha, Laura A. Wilson, Aynur Unalp, Rohit Loomba, Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Nathan M. Bass, . (2014) Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver International 34:10.1111/liv.2014.34.issue-8, 1250-1258
CrossRef75
Letizia Bresciani, Luca Calani, Renato Bruni, Furio Brighenti, Daniele Del Rio. (2014) Phenolic composition, caffeine content and antioxidant capacity of coffee silverskin. Food Research International 61, 196-201
CrossRef76
Rafael Franco, Angel Cedazo-Minguez. (2014) Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?. Frontiers in Pharmacology 5
CrossRef77
Federico Pietrocola, Shoaib Ahmad Malik, Guillermo Mariño, Erika Vacchelli, Laura Senovilla, kariman chaba, Mireia Niso-Santano, Maria Chiara Maiuri, Frank Madeo, Guido Kroemer. (2014) Coffee induces autophagy in vivo. Cell Cycle 13, 1987-1994
CrossRef78
Federico Salomone, Giovanni Li Volti, Paola Vitaglione, Filomena Morisco, Vincenzo Fogliano, Agata Zappalà, Angelo Palmigiano, Domenico Garozzo, Nicola Caporaso, Giuseppe D’Argenio, Fabio Galvano. (2014) Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. Translational Research 163, 593-602
CrossRef79
Taisha Doo, Yukiko Morimoto, Astrid Steinbrecher, Laurence N Kolonel, Gertraud Maskarinec. (2014) Coffee intake and risk of type 2 diabetes: the Multiethnic Cohort. Public Health Nutrition 17, 1328-1336
CrossRef80
Ina Marie Andersen, Guro Tengesdal, Benedicte Alexandra Lie, Kirsten Muri Boberg, Tom Hemming Karlsen, Johannes Roksund Hov. (2014) Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 12:6, 1019-1028
CrossRef81
Emmanuel A Tsochatzis, Jaime Bosch, Andrew K Burroughs. (2014) Liver cirrhosis. The Lancet 383, 1749-1761
CrossRef82
June M. Chan, Erin L. Van Blarigan, Stacey A. Kenfield. (2014) What should we tell prostate cancer patients about (secondary) prevention?. Current Opinion in Urology 24, 318-323
CrossRef83
Sammy Saab, Divya Mallam, Gerald A. Cox, Myron J. Tong. (2014) Impact of coffee on liver diseases: a systematic review. Liver International 34:10.1111/liv.2014.34.issue-4, 495-504
CrossRef84
Min Cheng, Zunsong Hu, Xiangfeng Lu, Jianfeng Huang, Dongfeng Gu. (2014) Caffeine Intake and Atrial Fibrillation Incidence: Dose Response Meta-analysis of Prospective Cohort Studies. Canadian Journal of Cardiology 30, 448-454
CrossRef85
Masafumi Katayama, Kenichiro Donai, Hiroyuki Sakakibara, Yukiko Ohtomo, Makoto Miyagawa, Kengo Kuroda, Hiroko Kodama, Kazufumi Suzuki, Noriyuki Kasai, Katsuhiko Nishimori, Takafumi Uchida, Kouichi Watanabe, Hisashi Aso, Emiko Isogai, Hideko Sone, Tomokazu Fukuda. (2014) Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the Long-Evans Cinnamon rat. Clinical Nutrition 33, 302-310
CrossRef86
A. J. Carman, P. A. Dacks, R. F. Lane, D. W. Shineman, H. M. Fillit. (2014) Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease. The journal of nutrition, health & aging 18, 383-392
CrossRef87
James J. DiNicolantonio, Sean C. Lucan, James H. O'Keefe. (2014) Is Coffee Harmful? If Looking for Longevity, Say Yes to the Coffee, No to the Sugar. Mayo Clinic Proceedings 89, 576-577
CrossRef88
Youjin Je, Edward Giovannucci. (2014) Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. British Journal of Nutrition 111, 1162-1173
CrossRef89
Wen-Xing Ding. (2014) Drinking coffee burns hepatic fat by inducing lipophagy coupled with mitochondrial β-oxidation. Hepatology 59, 1235-1238
CrossRef90
Yung-Chien Hsu, Pei-Hsien Lee, Chen-Chou Lei, Ya-Hsueh Shih, Chun-Liang Lin. (2014) Analgesic use, parents’ clan, and coffee intake are three independent risk factors of chronic kidney disease in middle and elderly-aged population: a community-based study. Renal Failure 36, 361-366
CrossRef91
Esther Lopez-Garcia, Pilar Guallar-Castillon, Luz Leon-Muñoz, Auxiliadora Graciani, Fernando Rodriguez-Artalejo. (2014) Coffee consumption and health-related quality of life. Clinical Nutrition 33, 143-149
CrossRef92
Amitava Dasgupta, Kimberly Klein. . Tea, Coffee, and Chocolate. 2014:, 237-257.
CrossRef93
Makoto Ayaori, Katsunori Ikewaki. . Role of ATP-Binding Cassette Transporters A1 and G1 in Reverse Cholesterol Transport and Atherosclerosis. 2014:, 103-131.
CrossRef94
Filomena Morisco, Vincenzo Lembo, Giovanna Mazzone, Silvia Camera, Nicola Caporaso. (2014) Coffee and Liver Health. Journal of Clinical Gastroenterology 48, S87-S90
CrossRef95
Gustavo D. Pimentel, Thayana O. Micheletti, Astrid Nehlig. . Coffee Intake and Obesity. 2014:, 245-259.
CrossRef96
Eliyahu Greitzer. (2013) Heavy Coffee Drinking and Age-Dependent All-Cause Mortality. Mayo Clinic Proceedings 88, 1492-1493
CrossRef97
Jeanette M. Bennett, Isabella M. Rodrigues, Laura Cousino Klein. (2013) Effects of Caffeine and Stress on Biomarkers of Cardiovascular Disease in Healthy Men and Women with a Family History of Hypertension. Stress and Health 29:10.1002/smi.v29.5, 401-409
CrossRef98
Michael G. Wagner, Kapil G. Kapoor, Alan L. Wagner. (2013) Factors Affecting the Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality. Mayo Clinic Proceedings 88, 1491-1492
CrossRef99
Vanessa Gonzalez-Covarrubias. (2013) Lipidomics in longevity and healthy aging. Biogerontology 14, 663-672
CrossRef100
M. I. Fernandez, Y. Gong, Y. Ye, J. Lin, D. W. Chang, A. M. Kamat, X. Wu. (2013) -H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer. Carcinogenesis 34, 2543-2547
CrossRef101
Vivian Ng, Sammy Saab. (2013) Can Daily Coffee Consumption Reduce Liver Disease–Related Mortality?. Clinical Gastroenterology and Hepatology 11, 1422-1423
CrossRef102
Milan S. Geybels, Marian L. Neuhouser, Jonathan L. Wright, Marni Stott-Miller, Janet L. Stanford. (2013) Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes & Control 24, 1947-1954
CrossRef103
Salman K. Bhatti, James H. O’Keefe, Carl J. Lavie. (2013) Coffee and tea. Current Opinion in Clinical Nutrition and Metabolic Care 16, 688-697
CrossRef104
Junxiu Liu, Xuemei Sui, Carl J. Lavie, James R. Hebert, Conrad P. Earnest, Jiajia Zhang, Steven N. Blair. (2013) Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality. Mayo Clinic Proceedings 88, 1066-1074
CrossRef105
Daniel Caldeira, Cristina Martins, Luís Brandão Alves, Hélder Pereira, Joaquim J Ferreira, João Costa. (2013) Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart 99, 1383-1389
CrossRef106
Salome A. Rebello, Rob M. van Dam. (2013) Coffee Consumption and Cardiovascular Health: Getting to the Heart of the Matter. Current Cardiology Reports 15
CrossRef107
H. Hallstrom, L. Byberg, A. Glynn, E. W. Lemming, A. Wolk, K. Michaelsson. (2013) Long-term Coffee Consumption in Relation to Fracture Risk and Bone Mineral Density in Women. American Journal of Epidemiology 178, 898-909
CrossRef108
James H. O'Keefe, Salman K. Bhatti, Harshal R. Patil, James J. DiNicolantonio, Sean C. Lucan, Carl J. Lavie. (2013) Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality. Journal of the American College of Cardiology 62, 1043-1051
CrossRef109
Jack E. James. (2013) Caffeine and Suicide: What Responsibility Should Epidemiologists Bear for How Their Published Findings Are Understood?. Journal of Caffeine Research 3, 99-100
CrossRef110
Claire Bosire, Meir J. Stampfer, Amy F. Subar, Kathryn M. Wilson, Yikyung Park, Rashmi Sinha. (2013) Coffee consumption and the risk of overall and fatal prostate cancer in the NIH-AARP Diet and Health Study. Cancer Causes & Control 24, 1527-1534
CrossRef111
Stefano Malerba, Federica Turati, Carlotta Galeone, Claudio Pelucchi, Federica Verga, Carlo La Vecchia, Alessandra Tavani. (2013) A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. European Journal of Epidemiology 28, 527-539
CrossRef112
Telma A.F. Corrêa, Marcelo M. Rogero, Bruno M. Mioto, Daniela Tarasoutchi, Vera L. Tuda, Luiz A.M. César, Elizabeth A.F.S. Torres. (2013) Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: A clinical trial. Nutrition 29, 977-981
CrossRef113
Kanae Mure, Shinya Maeda, Chizu Mukoubayashi, Kouichi Mugitani, Masataka Iwane, Fujihisa Kinoshita, Osamu Mohara, Tatsuya Takeshita. (2013) Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin. Nutrition 29, 982-987
CrossRef114
N. N. Maserejian, C. G. Wager, E. L. Giovannucci, T. M. Curto, K. T. McVary, J. B. McKinlay. (2013) Intake of Caffeinated, Carbonated, or Citrus Beverage Types and Development of Lower Urinary Tract Symptoms in Men and Women. American Journal of Epidemiology 177, 1399-1410
CrossRef115
Rishma Vidyasagar, Arno Greyling, Richard Draijer, Douglas R Corfield, Laura M Parkes. (2013) The effect of black tea and caffeine on regional cerebral blood flow measured with arterial spin labeling. Journal of Cerebral Blood Flow & Metabolism 33, 963-968
CrossRef116
Joanna Folwarczna, Maria Pytlik, Maria Zych, Urszula Cegieła, Ilona Kaczmarczyk-Sedlak, Barbara Nowińska, Leszek Śliwiński. (2013) Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats. Molecular Nutrition & Food Research, n/a-n/a
CrossRef117
Maria Simonsson, Viktoria Söderlind, Maria Henningson, Maria Hjertberg, Carsten Rose, Christian Ingvar, Helena Jernström. (2013) Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer Causes & Control 24, 929-940
CrossRef118
A. Cano-Marquina, J.J. Tarín, A. Cano. (2013) The impact of coffee on health. Maturitas 75, 7-21
CrossRef119
J. Danielsson, P. Kangastupa, T. Laatikainen, M. Aalto, O. Niemela. (2013) Dose- and Gender-dependent Interactions between Coffee Consumption and Serum GGT Activity in Alcohol Consumers. Alcohol and Alcoholism 48, 303-307
CrossRef120
Dawn M. Torres, Stephen A. Harrison. (2013) Is It Time to Write a Prescription for Coffee? Coffee and Liver Disease. Gastroenterology 144, 670-672
CrossRef121
Rosa Luisa Potenza, Monica Armida, Antonella Ferrante, Antonella Pèzzola, Alessandra Matteucci, Maria Puopolo, Patrizia Popoli. (2013) Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience Research 91:10.1002/jnr.v91.4, 585-592
CrossRef122
Steven Lehrer, Sheryl Green, Kenneth E. Rosenzweig. (2013) Coffee Consumption Associated with Increased Mortality of Women with Breast Cancer. Journal of Caffeine Research 3, 38-40
CrossRef123
Sascha A Müller, Nuh N Rahbari, Bruno M Schmied, Markus W Büchler. (2013) Can postoperative coffee perk up recovery time after colon surgery?. Expert Review of Gastroenterology & Hepatology 7, 91-93
CrossRef124
Aristo Vojdani, Igal Tarash. (2013) Cross-Reaction between Gliadin and Different Food and Tissue Antigens. Food and Nutrition Sciences 04, 20-32
CrossRef125
Hiroki Sugiura, Shinichi Demura, Yoshinori Nagasawa, Shunsuke Yamaji, Tamotsu Kitabayashi, Shigeki Matsuda, Takayoshi Yamada, Ning Xu. (2013) Relationship between Extent of Coffee Intake and Recognition of Its Effects and Ingredients. Detection 01, 1-6
CrossRef126
Kang-Woo Lee, Joo-Young Im, Jong-Min Woo, Hilary Grosso, Yoon-Seong Kim, Ana Clara Cristovao, Patricia K. Sonsalla, David S. Schuster, Marla M. Jalbut, Jose R. Fernandez, Michael Voronkov, Eunsung Junn, Steven P. Braithwaite, Jeffry B. Stock, M. Maral Mouradian. (2013) Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson’s Disease. Neurotherapeutics 10, 143-153
CrossRef127
Michael J Ormsbee, Dennison Thomas, William Mandler, Emery G Ward, Amber W Kinsey, Lynn B Panton, Timothy P Scheett, Shirin Hooshmand, Emily Simonavice, Jeong-Su Kim. (2013) The effects of pre- and post-exercise consumption of multi-ingredient performance supplements on cardiovascular health and body fat in trained men after six weeks of resistance training: a stratified, randomized, double-blind study. Nutrition & Metabolism 10, 39
CrossRef128
R. E. J. ROACH, B. SIEGERINK, S. le CESSIE, F. R. ROSENDAAL, S. C. CANNEGIETER, W. M. LIJFERING. (2012) Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels. Journal of Thrombosis and Haemostasis 10:10.1111/jth.2012.10.issue-12, 2519-2525
CrossRef129
(2012) Epidemiology of Caffeine Consumption and Association of Coffee Drinking with Total and Cause-Specific Mortality:An Interview with Neal D. Freedman, PhD, MPH. Journal of Caffeine Research 2, 153-158
CrossRef130
Liang Shen. (2012) Beneficial effects of coffee consumption go beyond antioxidation. Nutrition 28, 1194-1195
CrossRef131
Ashwani K. Singal, Michael R. Charlton. (2012) Nutrition in Alcoholic Liver Disease. Clinics in Liver Disease 16, 805-826
CrossRef132
M. Inoue, S. Tsugane. (2012) Insulin resistance and cancer: epidemiological evidence. Endocrine Related Cancer 19, F1-F8
CrossRef133
António Vaz Carneiro. (2012) Comment on “Association of coffee drinking with total and cause-specific mortality”. Revista Portuguesa de Cardiologia 31, 627-628
CrossRef134
(2012) Coffee Drinking and Mortality. New England Journal of Medicine 367:6, 575-577
Free Full Text135
(2012) Risk factors: Good news for regular coffee drinkers. Nature Reviews Cardiology 9, 374-374
CrossRef136
Jack E. James. (2012) Coffee and Mortality: Urgent Need for Clinical Trials to Assess Putative Benefits and Harms. Journal of Caffeine Research 2, 53-54
CrossRef137
António Vaz Carneiro. (2012) Comment on “Association of coffee drinking with total and cause-specific mortality”. Revista Portuguesa de Cardiologia (English Edition) 31:9, 627
CrossRef
- Letters
- Metrics
Social Media statistics are not yet available.